Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy

By                              

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1580-1586

Spandidos Publications

Access to resources Recommend Favorite

Simultaneous Radiochemotherapy Versus Concomitant Boost Radiation for Advanced Inoperable Head and Neck Cancer

By Schäfer Ulrich   Schüller Patrick   Micke Oliver   Willich Normann  

Acta Oncologica, Vol. 39, Iss. 4, 2000-10 ,pp. : 523-528

Informa Healthcare

Access to resources Recommend Favorite

Radiation therapy concurrent with weekly cisplatin therapy for loco-regionally advanced nasopharyngeal carcinoma: outcomes of a clinical trial

By Ma Daiyuan   Fu Chunqiao   Tan Bangxian   Liu Mi   Li Xianfu   Zhou Yeqin  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 4, 2011-04 ,pp. : 187-191

Springer Publishing Company

Access to resources Recommend Favorite

Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation

By Benasso M.   Lionetto R.   Corvo R.   Ponzanelli A.   Vitale V.   Rosso R.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1895-1898

Elsevier

Access to resources Recommend Favorite

Radiation Therapy and Concurrent Cisplatin in Management of Locoregionally Advanced Nasopharyngeal Carcinomas

By Serin Meltem   Erkal Haldun Ş.   Çakmak Ahmet  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1031-1035

Informa Healthcare

Access to resources Recommend Favorite